Supramolecular adducts of squaraine and protein for noninvasive tumor imaging and photothermal therapy in vivo
…, YX Lin, LL Li, Y Liu, U Mayerhöffer, P Spenst, JG Su… - Biomaterials, 2014 - Elsevier
Extensive efforts have been devoted to the development of near-infrared (NIR) dye-based
imaging probes and/or photothermal agents for cancer theranostics in vivo. However, the …
imaging probes and/or photothermal agents for cancer theranostics in vivo. However, the …
E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy …
WB Wang, Y Liang, YQ Jin, J Zhang, JG Su… - Journal of Molecular …, 2021 - Elsevier
The pandemic of the COVID-19 disease caused by SARS-CoV-2 has led to more than 200
million infections and over 4 million deaths worldwide. The progress in the developments of …
million infections and over 4 million deaths worldwide. The progress in the developments of …
[HTML][HTML] Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial
…, LF Du, K Xu, S Shao, Y Liang, Y Kang, JG Su… - Nature …, 2022 - nature.com
NVSI-06-08 is a potential broad-spectrum recombinant COVID-19 vaccine that integrates
the antigens from multiple SARS-CoV-2 strains into a single immunogen. Here, we evaluate …
the antigens from multiple SARS-CoV-2 strains into a single immunogen. Here, we evaluate …
[HTML][HTML] Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial
…, J Zhang, K Xu, Y Liang, Y Kang, JG Su… - … and Targeted Therapy, 2022 - nature.com
The increased coronavirus disease 2019 (COVID-19) breakthrough cases pose the need of
booster vaccination. We conducted a randomised, double-blinded, controlled, phase 2 trial …
booster vaccination. We conducted a randomised, double-blinded, controlled, phase 2 trial …
[HTML][HTML] Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2
Y Liang, J Zhang, RY Yuan, MY Wang, P He, JG Su… - Cell Discovery, 2022 - nature.com
The continuous emergence of SARS-CoV-2 variants highlights the need of developing
vaccines with broad protection. Here, according to the immune-escape capability and …
vaccines with broad protection. Here, according to the immune-escape capability and …
A peptide-coated gold nanocluster exhibits unique behavior in protein activity inhibition
Gold nanoclusters (AuNCs) can be primed for biomedical applications through functionalization
with peptide coatings. Often anchored by thiol groups, such peptide coronae not only …
with peptide coatings. Often anchored by thiol groups, such peptide coronae not only …
[PDF][PDF] Protein unfolding behavior studied by elastic network model
JG Su, CH Li, R Hao, W Zu Chen, CX Wang - Biophysical journal, 2008 - cell.com
Experimental and theoretical studies have showed that the native-state topology conceals a
wealth of information about protein folding/unfolding. In this study, a method based on the …
wealth of information about protein folding/unfolding. In this study, a method based on the …
A new residue‐nucleotide propensity potential with structural information considered for discriminating protein‐RNA docking decoys
CH Li, LB Cao, JG Su, YX Yang… - … : Structure, Function, and …, 2012 - Wiley Online Library
Understanding the key factors that influence the preferences of residue‐nucleotide interactions
in specific protein‐RNA interactions has remained a research focus. We propose an …
in specific protein‐RNA interactions has remained a research focus. We propose an …
[PDF][PDF] Analysis of domain movements in glutamine-binding protein with simple models
JG Su, X Jiao, TG Sun, CH Li, W Zu Chen, CX Wang - Biophysical journal, 2007 - cell.com
In this work, the mechanism of domain movements of glutamine-binding protein (GlnBP),
especially the influence of the ligand on GlnBP dynamic behavior is investigated with the aid of …
especially the influence of the ligand on GlnBP dynamic behavior is investigated with the aid of …
[HTML][HTML] Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus
…, ZH Lei, ZX Zhao, SX Li, ZM Liu, P Shan, YQ Jin, JG Su… - npj Vaccines, 2024 - nature.com
Respiratory syncytial virus (RSV) is one of the most important pathogens causing respiratory
tract infection in humans, especially in infants and the elderly. The identification and …
tract infection in humans, especially in infants and the elderly. The identification and …